We've partnered with @biological_e to advance the development and manufacture of their #COVID19 vaccine candidate 🔬
This is the 1⃣1⃣th COVID-19 vaccine programme CEPI has supported (1/5 🧵) ⏬ cepi.net/news_cepi/cepi…
We will initially contribute up to $5m to support scaling up the process for manufacturing the vaccine 🏭
We will also explore providing additional funding to potentially enabling the production of 100 million doses in 2021 🩺 (2/5)
.@biological_e initiated a Phase 1/2 clinical trial in India in November 🇮🇳, and expects interim data from the trial to be available in Q1 of 2021 (3/5)
CEPI and Bio E are committed to global equitable access of #COVID19 vaccines and have agreed that vaccine output funded by CEPI’s investment will be made available through the COVAX Facility, if proven safe and effective 🌍 (4/5)
CEPI CEO, Dr Richard Hatchett, said: "Bio E’s vaccine candidate has the potential to be produced at scale, and characteristics which could make it suitable for broad distribution in developing countries." 💬 (5/5)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Thanks to the vital work by scientists, healthcare workers, global health experts and many others, we have reached an extraordinary moment in the history of vaccinology but also medicine more generally 🔬
At the start of the year, we turned our attention to a novel and fast-spreading mystery virus 🌍
We responded quickly and in collaboration with our partners, announcing our first 3 vaccine programmes on 23 Jan 📅
Our partnership announced this week with @biological_e means that we have now supported the development 1⃣1⃣ #COVID19 vaccines🔬
Our vaccine portfolio has been built on the principles of speed 💨, scale 🧪🧪🧪 , and access 🌍
What is Chikungunya? What are its symptoms? Where does it occur? And how do we currently prevent infections?🤔 (1/5)
What is Chikungunya? 🦠
A mosquito-borne disease spread by infected female Aedes mosquitoes🦟
The term is derived from Makonde, a language spoken in Tanzania, meaning “disease that bends up the joints”.
@WHO's highlighted Chikungunya as a major public health risk (2/5)
What are symptoms of the disease? 🤒
Chikungunya causes fever, severe joint pain, muscle pain, headache, nausea, fatigue and rash. Joint pain is often debilitating and can vary in duration.
The disease shares some clinical signs with Dengue and Zika (3/5)